论文部分内容阅读
目的:探讨左炔诺孕酮宫内缓释系统治疗子宫腺肌症的疗效。方法:选择2011年4月～2013年4月,子宫腺肌症患者95例,随机分为2组,观察组放置左炔诺孕酮宫内缓释系统治疗,对照组服用药物治疗,比较2组痛经程度、经期、经量、经间期和子宫体积的变化。结果:放置6个月后,观察组疼痛评分低,经期、经量、经间期和子宫大小恢复正常,与对照组比较,差异有统计学意义。结论:子宫腺肌症利用左炔诺孕酮宫内缓释系统治疗效果更好,值得临床推广。
Objective: To investigate the efficacy of levonorgestrel-releasing intrauterine system in the treatment of adenomyosis. Methods: From April 2011 to April 2013, 95 patients with adenomyosis were randomly divided into 2 groups. The observation group was treated with levonorgestrel-releasing intrauterine system, while the control group was treated with drug. Group Dysmenorrhea, menstrual, menstrual flow, menstrual cycle and uterine volume changes. Results: After 6 months, the pain scores of the observation group were low, menstruation, menstrual flow, menstrual period and uterine size returned to normal. Compared with the control group, the difference was statistically significant. Conclusion: The treatment of adenomyosis with levonorgestrel intrauterine system is better and worthy of clinical promotion.